Anhui Provincial Administration for Market Supervision Food Safety Sampling Information Circular (Issue 47, 2022
Time of Update: 2022-12-29
After verification by the local market supervision department and the acceptance of its objections, the batch of unqualified products was produced by Wuhu Fanchang County Scherman Tea Industry Co.
A balanced diet blocks the sneak attack of colorectal cancer
Time of Update: 2022-10-19
Huang Rui said that at present, the cause of colorectal cancer is not clear, but there is a large amount of research evidence that colorectal cancer is closely related to the patient's environmental region, gender and age, family heredity, lifestyle, dietary nutrition, disease drugs and other factors.
Yuzhou Food and Drug Administration was honored in Yuzhou 2018 Spring Festival Gala
Time of Update: 2022-09-17
Hao Hongju, reporter Hu Jiaxi On the evening of February 7th, the Yuzhou 2018 Spring Festival Gala was performed in the studio hall of the Yuzhou Radio and Television Cultural Center. 80 people from
Kexing Pharmaceutical's Human Erythropoietin Injection was awarded the "Approval Notice for Supplementary Drug Application
Time of Update: 2022-03-07
On February 14, Kexing Pharmaceuticals announced that it received the “Approval Notice for Supplementary Drug Application” approved and issued by the State Food and Drug Administration on February 12.
Taiwan's Tea Pesticides Relaxation Standard Is The Tsai Administration Still Creditable
Time of Update: 2022-03-06
Taiwan’s "China Times" recently commented that this time Taiwan’s Food and Drug Administration has drastically relaxed the standards for pesticide residues in fruits and vegetables, which not only aff
Investigational Alzheimer's disease drug lecanemab receives US FDA Fast Track designation
Time of Update: 2022-02-23
A Phase 3 clinical study of lecanemab Clarity AD in early AD is ongoing and completed enrollment in March 2021 with a total of 1,795 patients .
The FDA has agreed that the Clarity AD results, when completed, could serve as a validation study to validate the clinical benefit of lecanemab .
Hongri Pharmaceutical: Rocuronium Bromide Injection Obtained Drug Registration Approval
Time of Update: 2022-01-11
On December 9, Hongri Pharmaceutical issued an announcement stating that the company had recently received a drug registration approval for rocuronium injection (2.
The imported rocuronium injection was approved for marketing in China in 2000.
In 2022, multinational pharmaceutical companies will continue to accelerate their "weight reduction" in China
Time of Update: 2022-01-08
The industry believes that the layoffs of the above-mentioned multinational pharmaceutical companies in China are actually not Nothing new .
In addition to layoffs, in fact, many multinational pharmaceutical companies including Pfizer, Roche, Merck and other companies have adjusted their organizational structures in China since the beginning of this year.
JAK inhibitors on the same track have repeatedly encountered safety issues. Pfizer, AbbVie, Eli Lilly...Who can break the game first
Time of Update: 2021-10-02
On the same day that Sanofi/Regeneron released the news, Pfizer also announced its research JAK1 inhibitor Abrocitinib head-to-head Dupixent for the phase 3 clinical JADE of moderate to severe atopic dermatitis.
Dongfang Huakang Chinese Medicine Yiqi Tongqiao Pills Approved for Listing
Time of Update: 2021-10-01
is the holder of the marketing license for the drug .
This product is a new traditional Chinese medicine compound preparation developed on the basis of clinical experience.
Drug Administration: Nanchang Huayi's first batch of medical devices is being recalled
Time of Update: 2021-09-05
On August 19, the State Food and Drug Administration issued an announcement to notify Nanchang Huayi of its voluntary recall of some of its products in violation of regulations .
The company immediately initiated the recall procedure for this batch of products .
China Food and Drug Administration: A batch of Philips Jinkewei medical devices is being recalled
Time of Update: 2021-09-05
On August 6, the State Food and Drug Administration issued an announcement to notify Philips Kingway (Shenzhen) Industrial Co.
Details are as follows:Philips Kingway (Shenzhen) Industrial Co.
Philips Kingway (Shenzhen) Industrial Co.
voluntarily recalled its electrocardiograph .
Shaanxi Buchang High-tech Pharmaceutical wins over $7 billion in star drug
Time of Update: 2021-08-27
A batch of antithrombotic drugs, the total sales of this product in China's public medical institutions and Chinese urban physical pharmacies in 2020 will be close to 4 billion yuan .
Significance of microbiological inspection and routine inspection items
Time of Update: 2021-08-20
Therefore, microbiological testing is an important means to ensure product quality and safety, and to prevent contamination by pathogenic microorganisms and the spread of diseases .
Betta Pharmaceuticals accepted the application for registration of first-line treatment indication drugs for Ensatinib Hydrochloride
Time of Update: 2021-08-06
On July 13, Betta Pharmaceuticals announced that it had received the "Notice of Acceptance" (acceptance number: CXHS2101028 country, CXHS2101029 country) issued by the State Food and Drug Administration, and the company declared Ensatinib Hydrochloride Capsules (Bemena ®) The application for marketing authorization for "applicable to the treatment of patients with anaplastic lymphoma kinase (ALK) positive locally advanced or metastatic non-small cell lung cancer (NSCLC)" has been accepted by the State Food and Drug Administration .